Literature DB >> 4228269

Clearance of uric acid, urea, and creatinine in Down's syndrome.

S P Coburn, M Seidenberg, E T Mertz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4228269     DOI： 10.1152/jappl.1967.23.4.579

Source DB:  PubMed          Journal:  J Appl Physiol        ISSN： 0021-8987            Impact factor:   3.531


× No keyword cloud information.
  11 in total

1.  Immunological and purine enzyme studies on hyperuricaemic and normouricaemic patients with Down's syndrome.

Authors:  R W Watts; Y S Perera; J Allsop; C Newton; T A Platts-Mills; A D Webster
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

2.  Neopterin: biopterin ratios in Down's syndrome.

Authors:  R J Cattell; C G Hamon; J A Corbett; J Lejeune; J A Blair
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-08       Impact factor: 10.154

3.  Assignment of a third purine biosynthetic gene (glycinamide ribonucleotide transformylase) to human chromosome 21.

Authors:  R G Hards; S J Benkovic; M L Van Keuren; S L Graw; H A Drabkin; D Patterson
Journal:  Am J Hum Genet       Date:  1986-08       Impact factor: 11.025

Review 4.  Renal anomalies in Down syndrome.

Authors:  A B Subrahmanyam; A V Mehta
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

5.  Renal involvement in Down syndrome.

Authors:  Serafín Málaga; Rafael Pardo; Ignacio Málaga; Gonzalo Orejas; Joaquín Fernández-Toral
Journal:  Pediatr Nephrol       Date:  2005-03-23       Impact factor: 3.714

Review 6.  Posterior urethral valves in patients with Down syndrome.

Authors:  J C Kupferman; C L Stewart; F J Kaskel; R N Fine
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

7.  Uric acid metabolism in two patients with coexistent Down's syndrome and gout.

Authors:  M L Ciompi; L M Bazzichi; D Bertolucci; M R Mazzoni; P Barbieri; S Mencacci; D Macchia; G Mariani
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

8.  Impact of acute kidney injury in patients prescribed angiotensin-converting enzyme inhibitors over the first two years of life.

Authors:  Daishi Hirano; Saori Miwa; Daisuke Kakegawa; Chisato Umeda; Yoichi Takemasa; Ai Tokunaga; Kawakami Yuhei; Akira Ito
Journal:  Pediatr Nephrol       Date:  2021-01-19       Impact factor: 3.714

9.  Widespread kidney anomalies in children with Down syndrome.

Authors:  Lavinia Postolache; Afshin Parsa; Paolo Simoni; Grammatina Boitsios; Khalid Ismaili; Thierry Schurmans; Anne Monier; Georges Casimir; Adelin Albert; Cameron F Parsa
Journal:  Pediatr Nephrol       Date:  2022-02-03       Impact factor: 3.651

Review 10.  Oxidative stress, thyroid dysfunction & Down syndrome.

Authors:  Carlos Campos; Ángela Casado
Journal:  Indian J Med Res       Date:  2015-08       Impact factor: 2.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.